Pramipexole-Rasagiline Combination Promising for Early Parkinson Disease Treatment
A novel combination of Pramipexole-Rasagiline is found to be promising in a recently concluded clinical trial for Early Parkinson Disease treatment. Top line results from this Phase III trial indicate the superiority of fixed-dose combination of extended release (ER) formulations of pramipexole and rasagiline (P2B001) in adults with early Parkinson disease. P2B001 has successfully met…
News Views